References
- Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991;3:243-54. https://doi.org/10.1176/jnp.3.3.243
- Barnhart WJ, Makela EH, Latocha MJ. SSRI-induced apathy syndrome: a clinical review. J Psychiatr Pract 2004;10:196-9. https://doi.org/10.1097/00131746-200405000-00010
- Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006;77:8-11. https://doi.org/10.1136/jnnp.2005.069575
- Padala PR, Burke WJ, Bhatia SC. Modafinil therapy for apathy in an elderly patient. Ann Pharmacother 2007;41:346-9. https://doi.org/10.1345/aph.1H302
- Roth RM, Flashman LA, McAllister TW. Apathy and its treatment. Curr Treat Options Neurol 2007;9:363-70. https://doi.org/10.1007/s11940-007-0022-5
- McPherson S, Fairbanks L, Tiken S, Cummings JL, Back-Madruga C. Apathy and executive function in Alzheimer's disease. J Int Neuropsychol Soc 2002;8:373-81. https://doi.org/10.1017/S1355617702813182
- Wongpakaran N, van Reekum R, Wongpakaran T, Clarke D. Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study. Ann Gen Psychiatry 2007;6:7. https://doi.org/10.1186/1744-859X-6-7
- Dubini A, Bosc M, Polin V. Do noradrenaline and serotonin differentially affect social motivation and behaviour? Eur Neuropsychopharmacol 1997;7(Suppl 1): S49-55. https://doi.org/10.1016/S0924-977X(97)00419-7
- Lanctot KL, Aguera-Ortiz L, Brodaty H, Francis PT, Geda YE, Ismail Z, et al. Apathy associated with neurocognitive disorders: Recent progress and future directions. Alzheimers Dement 2017;13:84-100. https://doi.org/10.1016/j.jalz.2016.05.008
- Galynker I, Ieronimo C, Miner C, Rosenblum J, Vilkas N, Rosenthal R. Methylphenidate treatment of negative symptoms in patients with dementia. J Neuropsychiatry Clin Neurosci 1997;9:231-9. https://doi.org/10.1176/jnp.9.2.231
- van Reekum R, Bayley M, Garner S, Burke IM, Fawcett S, Hart A, et al. N of 1 study: amantadine for the amotivational syndrome in a patient with traumatic brain injury. Brain Inj 1995;9:49-53. https://doi.org/10.3109/02699059509004571
- Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp B. Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 1995;7:23-30. https://doi.org/10.1176/jnp.7.1.23
- Debette S, Kozlowski O, Steinling M, Rousseaux M. Levodopa and bromocriptine in hypoxic brain injury. J Neurol 2002;249:1678-82. https://doi.org/10.1007/s00415-002-0903-1
- Newburn G, Newburn D. Selegiline in the management of apathy following traumatic brain injury. Brain Inj 2005;19:149-54. https://doi.org/10.1080/02699050410001719989
- Corcoran C, Wong ML, O'Keane V. Bupropion in the management of apathy. J Psychopharmacol 2004;18:133-5. https://doi.org/10.1177/0269881104043284
- Holmes C, Wilkinson D, Dean C, Vethanayagam S, Olivieri S, Langley A, et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology 2004;63:214-9. https://doi.org/10.1212/01.WNL.0000129990.32253.7B
- Zhang N, Wei C, Du H, Shi FD, Cheng Y. The effect of memantine on cognitive function and behavioral and psychological symptoms in mild-to-moderate Alzheimer's disease patients. Dement Geriatr Cogn Disord 2015;40:85-93. https://doi.org/10.1159/000430808
- Gerrard P, Malcolm R. Mechanisms of modafinil: a review of current research. Neuropsychiatr Dis Treat 2007;3:349-64.
- Camargos EF, Quintas JL. Apathy syndrome treated successfully with modafinil. BMJ Case Rep 2011;2011:pii: bcr0820114652.
- Marangell LB, Johnson CR, Kertz B, Zboyan HA, Martinez JM. Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study. J Clin Psychiatry 2002;63:391-5. https://doi.org/10.4088/JCP.v63n0503
Cited by
- Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome vol.12, pp.2, 2020, https://doi.org/10.14412/2074-2711-2020-2-48-56